We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Check the tariff classification for a heat and moisture exchanging filter.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Information about how to register your homeopathic medicinal product through the Simplified Homeopathic Registration Scheme or the UK Homeopathic National Rules Scheme
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Check the tariff classification for peptide nisin standardised with sodium chloride
Check the tariff classification for flavour pods.
Information to support your recovery after COVID-19.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Protocols and procedures for testing the value for cultivation or use (VCU) of agricultural crops.
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Jan - 31 Mar 2024.
Using an ecological momentary assessment to evaluate your digital health product.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Check the tariff classification for antimicrobial bathing systems.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
How the maritime industry should treat waste at sea and in ports, reduce oil and air pollution, and control ozone-depleting substances.
Information for patients, healthcare professionals and developers of new medicines
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.